Back

Compliance with the prescription of recommended medical therapy in trials comparing six versus 12 months or longer dual antiplatelet therapy: A systematic review and meta-analysis

European Journal of Preventive Cardiology

29 August 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Safi U Khan
Safi U Khan

Author

Guthrie Clinic Sayre , United States of America

Muhammad Shahzeb Khan
Muhammad Shahzeb Khan

Author

Edo Kaluski
Edo Kaluski

Author

Mohamad A Alkhouli
Mohamad A Alkhouli

Author

You may be interested in
thumbnail
Congress Presentation
Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis
27 August 2022
thumbnail
Congress Session
Young Investigators Award - Secondary Prevention and Rehabilitation
14 April 2023
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Antithrombotic prescription in secondary cardiovascular prevention: are we following the guidelines?
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources